Impact of Mindful Self-Compassion Therapy on Self Harm Behaviors, Emotional Regulation and Quality of Life Among Patients With Borderline Personality Disorder

August 29, 2025 updated by: Asma Mansoor, Fatima Jinnah Women University

Impact of Mindful Self-Compassion Therapy on Self Harm Behaviors, Emotional Regulation and Quality of Life Among Patients With Borderline Personality Disorder: A Randomized Controlled Trial

The primary purpose of the study is to investigate whether Mindful Self-Compassion (MSC) therapy can significantly reduce self-harm behaviors, improve emotional regulation, and enhance the quality of life in individuals diagnosed with Borderline Personality Disorder (BPD). The study aims to contribute to the existing literature by providing robust evidence on the efficacy of MSC therapy for BPD, which could inform clinical practices and improve treatment outcomes

Study Overview

Detailed Description

The current quantitative study will be carried out in two phases. A cross-sectional survey will assess quality of life, emotional regulation, psychological distress, self-harm behaviors, social support, and state of mindfulness during the first phase. A randomized controlled trial (RCT) will be done during the second phase where patients with Borderline Personality Disorder who are identified with psychological distress, low level of social support, and quality of life, will be categorized into two groups i.e. waitlist control group and intervention group through the process of randomization. Then Mindful Self Compassion therapy would be applied to participants in the intervention group. The control group is the waitlist control group so initially no intervention will be given to participants in the control group but the intervention will be given to the control group participants once the study is completed. The Mindful Self Compassion therapy would be implemented on participants using individual and in-person modes. The pre-and post-assessment will be done at Times 1 and 2 within and between control and interventional groups. After doing post-assessment the difference between pre and post-assessment will be compared to explore the efficacy of Mindful Self Compassion Therapy in patients with borderline personality.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Punjab Province
      • Rawalpindi, Punjab Province, Pakistan, 46000
        • Recruiting
        • Commandant Afimh
        • Contact:
          • Commandant Afimh
          • Phone Number: 0320 5080050
        • Contact:
        • Principal Investigator:
          • Asma Mansoor, PhD Scholar
      • Rawalpindi, Punjab Province, Pakistan, 46000
        • Recruiting
        • Farid Family Hospital
        • Principal Investigator:
          • Asma Mansoor, PhD Scholar
        • Contact:
          • Medical, Superintendent
          • Phone Number: (051) 5124470
        • Contact:
        • Sub-Investigator:
          • Sehrish Khan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 1. First time diagnosed non-hospitalized patients of Borderline Personality Disorder.

    2. Patients of Borderline Personality Disorder experiencing psychological distress,low level of quality of life, social support, emotional dysregulation would be included.

    3. Borderline Personality Disorder patients with age 18 years and above (both gender) from outpatient department (OPD) 4. Borderline personality patients who would be able to understand Urdu language and can give the informed consent

  • Exclusion criteria

The study would have the following exclusion criteria:

  1. Hospitalized patients of Borderline Personality
  2. Patients with Borderline Personality having other chronic co-morbid diseases such as cancer, cognitive deficits, and other chronic psychological disorders.
  3. Patients with Borderline Personality younger than 18 years of age

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Waitlist Control
Who would receive intervention after study completion

Mindful Self-Compassion (MSC) therapy is an 8-week program blending mindfulness and self-compassion to improve emotional resilience and well-being.

Week 1: Introduction - Learn the basics of mindfulness, self-compassion, and reframing self-critical thoughts with kindness.

Week 2: Mindfulness - Practice observing thoughts and emotions without judgment to build self-awareness.

Week 3: Self-Kindness - Develop skills to treat yourself with warmth and care during difficult times.

Week 4: Common Humanity - Explore shared human experiences to reduce feelings of isolation.

Week 5: Working with Challenges - Learn strategies to respond compassionately to emotional pain.

Week 6: Growing Compassion - Deepen compassion for yourself and others through guided exercises.

Week 7: Resilience Building - Strengthen coping skills and foster emotional flexibility.

Week 8: Integration - Consolidate skills to maintain self-compassion in daily life.

Experimental: Experimental
Who receives intervention i.e. Mindful Self Compassion Therapy

Mindful Self-Compassion (MSC) therapy is an 8-week program blending mindfulness and self-compassion to improve emotional resilience and well-being.

Week 1: Introduction - Learn the basics of mindfulness, self-compassion, and reframing self-critical thoughts with kindness.

Week 2: Mindfulness - Practice observing thoughts and emotions without judgment to build self-awareness.

Week 3: Self-Kindness - Develop skills to treat yourself with warmth and care during difficult times.

Week 4: Common Humanity - Explore shared human experiences to reduce feelings of isolation.

Week 5: Working with Challenges - Learn strategies to respond compassionately to emotional pain.

Week 6: Growing Compassion - Deepen compassion for yourself and others through guided exercises.

Week 7: Resilience Building - Strengthen coping skills and foster emotional flexibility.

Week 8: Integration - Consolidate skills to maintain self-compassion in daily life.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
World Health Organization Quality of Life Scale Urdu Version
Time Frame: 3 months
It has 26 items and four domains: physical health (7 items), psychological health (6 items), social relationships (3 items), and environmental health (8 items); it also contains quality of life and general health items. The minimum value is 26 and the maximum value is 130. Higher scores on the scale indicate higher quality of life and low scores indicate low quality of life.
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Asma Mansoor, PhD Scholar, Fatima Jinnah Women University, Rawalpindi, Pakistan

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 21, 2024

Primary Completion (Estimated)

December 30, 2025

Study Completion (Estimated)

December 30, 2025

Study Registration Dates

First Submitted

November 19, 2024

First Submitted That Met QC Criteria

November 19, 2024

First Posted (Actual)

November 21, 2024

Study Record Updates

Last Update Posted (Estimated)

September 2, 2025

Last Update Submitted That Met QC Criteria

August 29, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Due to ethical concerns the data will not be shared. All research findings will be published in aggregate form maintaining patient anonymity

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Psychological Distress

Clinical Trials on Mindful Self Compassion Therapy

Subscribe